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Human enterovirus type 71 (EV71), the major causative agent of hand-foot-and-mouth
disease, has been known to cause fatal neurological complications. Unfortunately, the
reason for neurological complications that have been seen in fatal cases of the disease
and the relationship between EV71 virulence and viral genetic sequences remains largely
undefined. The 3C protease (3Cpro) of EV71 plays an irreplaceable role in segmenting
the precursor polyprotein during viral replication, and intervening with host life activity
during viral infection. In this study, for the first time, the 69th residue of 3C protease has
been identified as a novel virulence determinant of EV71. The recombinant virus with
single point variation, in the 69th of 3Cpro, exhibited obvious decline in replication, and
´virulence. We further determined the crystal structure of 3C N69D at 1.39Å resolution
and found that conformation of 3C N69D demonstrated significant changes compared
with a normal 3C protein, in the substrate-binding site and catalytic active site. Strikingly,
one of the switch loops, essential in fixing substrates, adopts an open conformation
in the 3C N69D-rupintrivir complex. Consistent with this apparent structural disruption,
the catalytic activity of 3C N69D decreased sharply for host derived and viral derived
substrates, detected for both in vitro and in vivo. Interestingly, in addition to EV71, Asp69
was also found in 3C proteases of other virus strains, such as CAV16, and was conserved
in nearly all C type human rhinovirus. Overall, we identified a natural virulence determinant
of 3C protease and revealed the mechanism of attenuated virulence is mediated by
N69D substitution. Our data provides new insight into the enzymatic mechanism of a
subdued 3C protease and suggests a theoretical basis for virulence determinantion of
picornaviridae.
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INTRODUCTION
Enterovirus 71 (EV71) is the major causative agent of hand-foot-and-mouth disease (HFMD)
particularly aiming young children and infants (Shindarov et al., 1979; Lum et al., 1998; Ho, 2000;
Yang et al., 2009). This virus belongs to the picornaviridae family and consists of a∼7400 bp positive
single-stranded RNA and exhibits frequent variation (Lum et al., 1998; Ho, 2000). Since the first
Li et al. A Novel EV71 Virulence Determinant
reported HFMD outbreak in California in 1969, it has become
a continuing threat to global public health especially in the
Asia-Pacific region. After the unusual HFMD outbreak in
2008, HFMD was designated one of the national infectious
diseases of China due to its substantial morbidity and mortality
(Yang et al., 2009). The total number of HFMD was reported
of about 12,800,000 cases by the end of 2015 in China
mainland, including about 580,000 severe cases and 3296 fatal
cases. The clinical characterizations of HFMD are prodromal
fever followed by pharyngitis, mouth herpes, and rash on the
hands and feet (Huang et al., 1999; Ho, 2000). Most patients
recovered within a week, but a few severe cases suffered from
neurological complications including convulsion, ataxia, brain-
stem encephalitis, poliomyelitis-like paralysis, and even death
(Lum et al., 1998; Huang et al., 1999). Although an inactivated
enterovirus 71 vaccine has been developed recently, the efficacy,
and safety of this vaccine remain to be further tested (Li et al.,
2014; Zhu et al., 2014). The pathogenic mechanism of EV71
remains unclear. Most importantly, the reason for neurological
complications of severe cases or fatal cases remains largely
undefined. It has been reported that both the host’s immune state
and viral genetic sequences contribute to the severity of HFMD
(Huang et al., 1999; Weng et al., 2010).
In the past, there were a few reports demonstrating that
the pathogenicity of EV71 can be enhanced or weakened by a
single mutation of its genome. For instance, researchers found
that mutation of the receptor interacting region of EV71 VP1
or the palm domain and finger domain of EV71 3D will lead
to attenuated virus virulence in the EV71 B or C1 genotype
(Meng and Kwang, 2014; Zhang et al., 2014; Yuan et al., 2015).
However, for the EV71 C4 genotype, the most predominant
EV71 strain currently in China, there is little known about the
virulence determinants or the molecular mechanisms underlying
the attenuated phenotype. Previously, our group isolated six
EV71 strains from patients of Jinan, China during 2008 and 2010
(Li et al., 2016). Those EV71 strains, which were identified as
the C4 genotype, were classified into two classes according to the
infection-induced fatality of 1-day-old mice. Sequence analysis
demonstrated eight substitutions in amino acids between lethal-
strains and a non-lethal strain. In this study, we attempted to
elucidate the virulence determinants of the EV71 C4 genotype
and the molecular basis of the underlying pathogenic difference.
To do this, we used a reverse genetics approach to establish eight
recombinant viruses with a single amino acid substitution and
compared the replication ability of these viruses with wild-type.
Interestingly, only the variant with a mutant in the 69th residue
of 3Cpro exhibited significant differences from the WT strain.
The genome of EV71 encodes a precursor polyprotein of
∼2193aa in length which is incised into four viral structural
proteins (VP1, VP2, VP3, VP4) and seven functional proteins
(2A, 2B, 2C, 3A, 3B, 3C, 3D) during virus replication (Ho,
2000). All the proteolytic processes of EV71 polyprotein are
performed by its 3C protease except the cleavage of VP1-2A
and VP2-VP4 (Parks et al., 1989; Dasmahapatra et al., 1992).
More importantly, like other picornaviral 3C proteases, EV71
3Cpro can impair host cellular functions by hydrolysis of host
targets (Kuyumcu-Martinez et al., 2004a,b; Strong and Belsham,
2004; Kundu et al., 2005; Bonderoff et al., 2008; De Breyne
et al., 2008; Xiang et al., 2014). Wang et al. reported that EV71
3Cpro interferes with host RNA polyadenylation by digesting the
host protein CstF-64, a cleavage stimulating factor responsible
for 3′ pre-mRNA cleavage and polyadenylation (Weng et al.,
2009). More recently, EV71 3Cpro was found to inhibit host
immune responses by cleavage of the adaptor protein TRIF and
interferon regulatory factor 7 (IRF7) (Lei et al., 2013). Those
findings suggest that EV71 3Cpro plays a significant role in both
virus replication and virus-host interaction. Our results indicated
that mutation of the 69th residue of EV71 3Cpro provides a
distinct reduction of viral replication to attenuate virulence of the
virus. However, themechanism by which the 3Cpro N69Dmutant
alters virulence has not been determined. For this purpose,
we determined the crystal structure of 3Cpro N69D at 1.4 Å
resolution. Structural analysis combined with enzymatic activity
assays revealed dramatic structural and functional changes of
3Cpro N69D compared with native 3Cpro which may explain
the molecular mechanism of the reduced virulence of the EV71
non-lethal strain.
MATERIALS AND METHODS
Construction of Single Mutant EV71
Plasmids and Transfection
Eight mutational plasmids were amplified from A12 plasmids
(infectious full-length cDNA of EV71 containing a SP6 promoter,
gifted by the Academy of Military Medical Sciences, Beijing,
China) using a Site-Directed Mutagenesis system (TransGen
biotech, Beijing, China; Cao et al., 2013). PCR products were
digested with DMT enzyme (TransGen) at 37◦C for 1 h and
transformed into DMT cells (TransGen). Then, Plasmids were
digested with MluI Enzyme (Thermo Scientific, Rockford, IL,
USA) for 30 min at 37◦C and further purified using DNA
Purification Kit (Thermo). Linearized DNA was transcribed into
RNA using SP6 in vitro Transcription Kit (Thermo) according to
the instructions. The reaction mixtures were incubated at 37◦C
for 2 h, followed by treatment with DpnI enzyme (Thermo) at
37◦C for 5 min. The transcripts were purified using an RNA
Purification Kit (Thermo). About 1 ng RNA transcripts were
mixed with moderate Lipofectamine 2000 reagent (Invitrogen,
USA) for 15 min at room temperature. The mixtures were then
added to Rhabdomyosarcoma (RD) cells or 293T cells in a 24-
plate and incubated at 37◦C with 5% CO2. Cell cultures were
harvested when the cytopathic effect (CPE) reached 70–80% and
stored at−80◦C.
RT-PCR
Total RNA was extracted from cell cultures infected by
rescued virus using the viral RNA Kit (TransGen). The
reverse transcription reactions were performed using Revert
Aid cDNA Synthesis Kit (Thermo) with Oligo (dT) as primer
and incubated at 42◦C for 1 h, followed by 10 min at 70◦C.
RT-PCR was performed by EV71 specific primers (forward
primer: 5′-GCAGCCCAAAAGAACTTCAC-3′, reverse primer:
5′-ATTTCAGCAGCTTGGAGTGC-3′) in a volume of 25 µl.
After electrophoresis, PCR products were purified using DNA
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Purification Kit (Thermo) and sequenced (Biosune, Shanghai,
China).
Replication Kinetics
RD cells seeded in a 24-well plate with 90% confluency were
infected with rescued virus at a Multiplicity of Infection (MOI)
of 1 and cultured at 37◦C for 1 h, followed by washing three
times with PBS to remove unattached virus. Then, 2% FBS-
1640 medium was added. Cells and supernatants were sampled
at 6, 12, 24, 48, and 60 h post infection. The quantitative RT-
PCR reactions were performed on an Applied Biosystems 7500
Sequence Detection system (Applied Biosystems, Foster, CA,
USA) to quantify viral RNA copies (Li et al., 2015). The reaction
system contained 0.1 µl of cDNA of samples and 12.5 µl of SYBR
Green qPCR Master Mix (Thermo), 0.05 µl of 10-fold dilutions
of ROX, and 0.3 µM of each EV71 specific primer in 25 µl of
reaction volume. The A12 plasmids were serially diluted 10-fold
and were used as a reference standard to generate the standard
curve and quantify viral RNA copies. All samples were detected
in triplicate.
Western Blot and Antibodies
RD cells or 293T cells infected with RNA transcripts or plasmids
were cultured at 37◦C with 5% CO2 for different amounts of
time and then lysed in a SDS–PAGE loading dye, followed by
heating at 95◦C for 10 min before separation by SDS-PAGE. Cells
infected with wild type EV71 were used as positive controls and
uninfected cells were used as negative controls. Total proteins on
gels were transferred to nitrocellulose membranes at 250 mA for
2 h in transfer buffer (96 mM glycine, 12.5 mM Tris and 10%
methanol). The membranes were blocked in 5% milk soluted
in PBS-0.1% Tween 20 (PBST) at 37◦C for 1 h, followed by
incubation with indicated primary antibodies in PBST over night
at 4◦C. The membranes were washed three times in PBST and
then incubated at 37◦C for 1 h in secondary antibody diluted
1:10000 in PBST. The membranes were washed three times for
10 min and then detected by chemiluminescence.
Antibodies against IRF7, NF-κB, HRP Conjugated Goat anti
Rabbit IgGH&L and Goat Anti-Mouse IgGH&L were purchased
from abcam (UK). Anti-GADPH was purchased from Cell
Signaling Technology (Danvers, MA). Anti-EV71 3C and anti-
EV71 3D antibodies were purchased from GeneTex (UK).
Indirect Fluorescent-Antibody (IFA) Assay
RD cells seeded on a slide were infected with rescued virus and
cultured for 12 h at 37◦C with 5% CO2. Cells infected with wild
type EV71 were used as positive controls and uninfected cells
were used as negative controls. Cells were washed with PBS and
fixed in 4% paraformaldehyde (soluted in PBS) at 4◦C for 30 min,
then blocked in 5% blocking milk for 1 h at room temperature.
Then, cells were washed with PBS and incubated over night at
4◦C with mouse polyclonal antibody to EV71 (GeneTex) diluted
1:200 in PBS. Cells on slides were washed again before incubation
with Goat Anti-Mouse IgG H&L (abcam) diluted 1:500 in PBS at
37◦C for 1 h. Finally, RD cells were washed with PBS three times
for 5 min and then visualized under a fluorescent microscope.
Protein Expression and Purification
The native 3C and 3C N69D genes were amplified from the
cDNA of EV71 lethal-strains and non-lethal strain and cloned
into the pGL01 vector, a modified vector based on pET15b with
a Prescission Protease (PPase) cleavage site to remove the 6
× His tag after purification (Li et al., 2012). The 3C C147S
mutant was constructed using a two-step PCR strategy and also
cloned into pGL01. The protein-encoding plasmids were grown
and expressed in E. coli BL21 (DE3) in LB medium with 100
µg/ml Ampicillin. When the OD600 reached 0.6, cultures were
cooled to 16◦C and induced overnight by addition of 0.1 mM
IPTG. Harvested cells were resuspended in lysis buffer (25 mM
Tris-HCl pH 8.0, 200 mM NaCl) and lysed by sonication. After
centrifugation at 28,500 × g for 45 min, proteins were purified
by Ni2+-NTA affinity column and the His-tag was removed
using PPase for 5 h. The target proteins lacking the His-tag were
concentrated to 2 ml and purified by Superdex 200 in buffer
containing 10 mM Tris-HCl pH 8.0 and 100 mM NaCl. Purified
proteins were stored at−80◦C. Genes of the native 3C, 3C N69D,
and 3C C147S were also cloned into pFLAG-CMV2 vector for
in vivo experiment. Recombinant plasmids were transfected into
293 T cells using liposomes. The intracellular expression of IRF7
was detected by immunoblotting.
Crystallization and Structure
Determination
3C N69D were concentrated to about 10 mg/ml and rupintrivir
dissolved in DMSO was added to a final concentration of 3 mM.
After incubation on ice for 10 min, the mixtures were centrifuged
before crystallization (Wang et al., 2011). The crystals were
obtained in the presence of 30% PEG 8000 and 0.1 M sodium
acetate (pH 4.5) after 7 days. To prevent radiation damage,
crystals were equilibrated in a cryoprotectant buffer containing
15% glycerol (v/v) plus reservoir buffer and then flash frozen
in a 100K nitrogen stream. Diffraction data were collected at
Shanghai Synchrotron Radiation facility (SSRF) beamline BL17
ul. The data set was processed using the HKL2000 software
suite. The structure was solved by molecular replacement using
PHASER with native 3C (PDB: 3SJO) as the searching model.
The atomic model was built using Coot and refined using
PHENIX (Adams et al., 2002; Emsley and Cowtan, 2004). Data
collection and structure refinement statistics are summarized in
Table 1. Structural figures were generated using PyMol (http://
www.pymol.org).
Protease Activity Assay
Six fluorogenic peptides, joined with an N-terminal Dabcyl
group and C-terminal Edans group, were used as substrates and
recombinant EV71 3Cpro, 3C N69D, and 3C C147S protein were
used as enzymes in the protease activity assays. Reactions were
performed in a system containing 50 mM Tris-HCl (pH 7.0),
200 mM NaCl and 2 mM dithiothreitol (DTT) with a final
concentration of 5.6 µM enzymes and substrates at different
concentrations (3–45 µM) (Cui et al., 2011; Lu et al., 2011).
After being mixed for 2 min, the relative hydrolysis rates were
determined by monitoring fluorescence using a Cary Eclipse
fluorescence spectrophotometer. The excitation wavelength was
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TABLE 1 | Data collection and refinement statistics.
3C N69D–Rupintrivir
Resolution range (Ã...) 20.53–1.39 (1.44–1.39)
Space group P21
Unit cell 36.2 64.8 38.3 90 113.1 90
Unique reflections 32549 (3195)
Completeness (%) 99.3 (98.6)
Mean I/sigma (I) 22.38 (4.84)
Wilson B-factor 13.7
R-factor 0.174 (0.228)
R-free 0.199 (0.252)
Number of atoms 1764
macromolecules 1475
ligands 53
water 239
Protein residues 182
RMS(bonds) 0.008
RMS(angles) 1.19
Ramachandran favored (%) 98
Ramachandran outliers (%) 0
Clashscore 4.87
Average B-factor 20.39
Macromolecules 18.10
Ligands 26.10
Solvent 33.42
Statistics for the highest-resolution shell are shown in parentheses.
340 nm, and emission was measured at 500 nm. Initial hydrolysis
rates were recorded for each substrate concentration. Data were
fitted to the Michaelis-Menten equation to calculate kinetic
parameters Km, maximum rate of metabolism (Vmax), and
Km/kcat (Origin).
ELISA
The concentrations of IFN-α in culture supernatants were
measured by ELISA kits (R&D Systems). Briefly, RD cells were
infected with H virus or L virus at MOI of 10 and cultured at
37◦C for 6, 12, 24, and 36 h and then the culture supernatants
were measured. Three experiments were performed for each time
point.
RESULTS
Construction of Eight Recombinant EV71
Viruses
Previously, we had isolated six EV71 strains from patients of
the Jinan Infectious Diseases Hospital (Jinan, China) in 2008
and 2010 (Li et al., 2016). Animal experiments showed that
these viruses exhibited different pathogenicity toward neonatal
mice. Five of those viruses lead to the death of 1-day-old
BALB/c mice and were designated the EV71 lethal-strain, and
the one isolated from the mildly infected patient and conferred
no symptoms to 1-day-old BALB/c mice was designated the
non-lethal strain. Sequences of those viruses were published
FIGURE 1 | M7 shows a different replication curve compared with wild
type and other variants. (A) Schematic illustration of the proteinic
architecture of EV71 virus. The positions of residues that differ between the
lethal strain and the non-lethal strain are marked as M1–M8. (B) Replication
kinetics of wild-type EV71 and 8 recombinant viruses. The copies of EV71
genome replication in wild-type EV71 and 8 recombinant viruses were
observed through RT-PCR. A12, a plasmid encoded complete cDNA of EV71,
was employed to set up a standard curve. The proliferation curves
demonstrated that the viral cDNA copies of M7 did not amplified as well as
wild-type EV71 and other recombinant viruses.
in Genebank: HQ825317, JQ074187, JQ074188, JQ074189, and
JQ074190 for the lethal-strain and JF913464 for non-lethal
strain. Interestingly, there are only eight differences in sequences
of amino acids between the lethal-strains and the non-lethal
strain (Table S1). To identify the genetic basis of the different
pathogenicity of EV71 and the contributions of the amino
acid substitutions to attenuation of virulence, eight single point
recombinant virus were constructed based on A12 recombinant
plasmid which include whole genome of a lethal-strain (GenBank
no. HQ611148; Han et al., 2010; Cao et al., 2013; Li et al., 2015).
Each variant included one amino acid replacement from the non-
lethal strain, named M1 to M8 successively. The descriptions of
those mutants are listed in Table S1, Figure 1A.
Characterization of Eight Recombinant
EV71 Viruses
After transfection with same amount of RNAs, the typical
cytopathic effect (CPE) appeared after 24 h in all genetically
modified EV71 variants except M7. In parallel, the phenotype of
CPE in M7-infected RD cells appeared after 2 days, weaker than
the others (Figure S1). However, the expression of proteins by
M1-M8 did not show significant differences when determined
by immunoblotting at 24 h post infection, suggesting that
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differences in pathogenicity were not caused by differences
in protein expression (Figure S2A). Additionally, indirect
fluorescent-antibody (IFA) results showed that percentages of
IFA-positive cells were obviously reduced in M7 but other
mutants were more similar to WT (Figure S2B). The CPE was
transmissible from the supernatant of the transfected cells for
rescued EV71 virus variants to fresh cells expect for M7, which
exhibited defective formation of new virus particles. We did
not obtain the culturable virus of M7 despite multiple attempts.
Replication kinetics of the rescued EV71 variants (M1, M2, M3,
M4, M5, M6, M8) and WT virus (H, A12) were performed by
quantitative RT-PCR using virus-infected cells with virus while
M7 replication kinetics were determined with the transfected
cell of RNA transcripts (Figure 1B). Results showed that mutant
viruses grew as well as the WT virus but the intracellular RNA of
M7 amplified weakly and tended to a decline after 24 h. The above
data suggested that the single substitution in M7 may cause great
changes in pathogenicity of EV71 virus. Bioinformatics analysis
showed that the substitution of M7 was of the 69th residue of 3C
protease, very close to the activity center of 3C protease based
on the crystal structure of EV71 wild-type 3Cpro determined
previously (Costenaro et al., 2011; Cui et al., 2011; Wang et al.,
2011; Wu et al., 2013). Wang et al. reported that Asn69 of 3Cpro
is associated with the hydrolytic activity of 3C protease (Wang
et al., 2011).
Crystal Structure Of 3Cpro N69D with
Rupintrivir
To determine the molecular mechanism underlying the above
phenomenon, we used an x-ray crystallographic approach to
determine the structure of the 3C N69D mutant. Perhaps due to
conformational change, numerous screens for the crystallization
of 3C N69D failed to give a hit but the 3C N69D-rupintrivir
complex crystallized successfully. The structure was determined
at 1.39 Å´ resolution using a molecular replacement approach
based on the previous 3C structure (PDB code: 3SJO) as searching
model (Lu et al., 2011). The crystals belong to the P21 space
group, containing two 3C N69D-rupintrivir complexes per
asymmetric unit. Data-collection and refinement statistics are
presented in Table 1.
Overall, the 3Cpro N69D folds into two domains similar
to native 3C with well-defined electron density (Figure 2A).
Structural alignment between the native 3Cpro-rupintrivir
complex (3SJO or 4GHT) and the 3Cpro N69D-rupintrivir
complex yielded a root mean square deviation (RMSD) of 0.72–
0.89 Å over 180 Cα-atom pairs as calculated by PDBeFold
server. The structure of the 3C N69D-rupintrivir complex was
superimposed with structures of the unliganded native 3C and
3C-rupintrivir complexes respectively (Figure 2B). As reported
previously, there are two regions of 3C that are involved in
rupintrivir and substrate binding, “switch loop I” and “switch
loop II” (also known as β-ribbon; Birtley et al., 2005; Lee et al.,
2009; Costenaro et al., 2011; Lu et al., 2011). Both switch loop
I and switch loop II of the native 3Cpro demonstrated dramatic
conformational changes after rupintrivir binding, converting
from an “open” state to a “closed” state (Cui et al., 2011; Lu
et al., 2011). However, unexpectedly, the switch loop II of 3C
N69D-rupintrivir structure displays a “closed” state while the
state of switch loop I remains “open” (Figure 2B). Structural
analysis showed that the 69th residue located on one side of swich
loop I, the N69D mutation leads to a series of comformation
changes in the residues of the active center. As a result, the
location of rupintrivir changed and switch loop I remains
“open”in the structure of 3C N69D (Figures 2C,D).
Rupintrivir interacts with the active site of EV71 3Cpro via
a network of hydrogen bonds and hydrophobic interactions.
Unsurprisingly, the binding mode of rupintrivir in our structure
is similar with those reported previously (Figure 2C; Costenaro
et al., 2011; Cui et al., 2011; Lu et al., 2011). However, we observed
significant discrepancies between the native 3Cpro-rupintrivir
complex and the 3Cpro N69D-rupintrivir complex at the P1′
and P2 sites of rupintrivir. First, the ester chain of P1′ group
is exposed to the solvent in the native 3C structure, while it
forms hydrogen bonds with the carbonyl oxygen of Gln22 in 3C
N69D structure (Figure S3). As a result, the terminal atoms at
P1′ in 3C N69D are in exactly the opposite direction compared
to the ones in the native 3C structure. Second, according to the
substitution of N69D, the P2 group makes a rotary movement of
2.28 Å relative to the position in native 3C. It is reported that
the displacement of the P2 group of rupintrivir in EV71 3C and
HRV 3C structure is only 1.6 Å despite a sequence identity of
only 50% (Wu et al., 2013). The above results suggested that the
single substitution of N69D may lead to obvious variation in the
binding of 3CN69D to the inhibitor and substrate compared with
native 3Cpro.
The Overturned Conformation in the Active
Site of 3Cpro N69D
In the structures of most of active sites of picornaviral 3Cpro,
the catalytic triads His40, Glu71, and Cys147 adopt similar
conformations that are stabilized via a series of hydrogen bonding
interactions (Birtley et al., 2005; Lee et al., 2009; Zunszain
et al., 2010; Costenaro et al., 2011; Cui et al., 2011; Lu et al.,
2011). In particular, the side chain and main chain of Glu71 are
hydrogen bonded by the surrounding residues in the structure of
native EV71 3C-rupintrivir complex (dotted lines in Figure 2D).
The glutamic acid side chain of Glu71 is immobilized by the
hydrogen bonds from the backbone NH of His40, the Nδ2
atom of Asn69, and Nη2 & Nε atoms of Arg39. Wang et al
suggested the firm conformation of catalytic center, especially
residues Glu71, might be important for substrate recognition and
catalytic activity (Wang et al., 2011). Unexpectedly, almost all the
residues located in the active center of EV71 3C N69D exhibit
dramatic changes when compared with the native 3C structure.
Strikingly, expect for Cys147, the catalytic triads showed an
overturned conformation never reported previously (Figure 2D).
When Asn69 is replaced by Asp, the aspartic acid side chain
of Asp69 uplifts and reverses 90◦C forming a stable state via
electrostatic interactions with the side chains of Arg39 andGlu61.
As a result, the interaction between Glu71 and Asn69 is abrogated
and there is a repellant force between two negative charge side
chain residues. Furthermore, the hydrogen bonds donated by
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5 February 2017 | Volume 7 | Article 26
Li et al. A Novel EV71 Virulence Determinant
FIGURE 2 | Crystal structure of 3Cpro N69D with rupintrivir. (A) Overall view of 3Cpro N69D-rupintrivir complex. Rupintrivir was shown as yellow sticks. (B)
Binding of rupintrivir leads to different conformational changes for 3C and 3C N69D. The structure of WT 3C with or without rupintrivir (PDB no: 4GHT and 3OSY) are
shown in blue and cyan, respectively. The 3C mutant N69D (PDB no: 5WQ2) is colored with hot pink. Two regions, responsible for substrate binding, are marked with
dotted ovals and labeled as “Switch loop I” and “Switch loop II.” (C) Structural comparison of WT 3C-rupintrivir and 3C N69D-rupintrivir (PDB no: 4GHT and 5WQ2).
WT 3C-rupintrivir and 3C N69D-rupintrivir are shown in yellow and green, respectively. Rupintrivir, Glu71, and Asp69/Asn69 are shown in the stick model. The 2.8-Å
(Continued)
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FIGURE 2 | Continued
uplift of the P2 group of rupintrivir in 3C N69D relative to the position in WT 3C is indicated. The shifts of the positions of Glu71 and Asp69/Asn69 are marked and the
distances between residues are annotated. (D) The N69D mutation leads to radical structural changes in the active center of 3Cpro. Structural superposition of native
3C and 3C N69D was shown in cartoon model and residues in the active site are shown in stick model. Native 3C and 3C N69D are rendered in blue and pink,
respectively. The hydrogen bond network of the active site of WT 3C is indicated with dashed lines. Residues involved in the hydrogen bond network of the active site
are annotated. The shifts in the position of residues in active center are indicated with arrows.
Arg39 are also disrupted because they are moved too far apart
for interaction. Glu71 in 3C N69D structure shifts away fromHis
40 compared with native 3C, making the conformation of active
center completely collapsed.
Enzymatic Activity of 3Cpro N69D
Decreased Sharply Both in vitro and in vivo
The structure of 3C N69D reveals great changes in the active
center indicating that 3C N69D may present different enzymatic
activities and substrate specificities compared with native 3Cpro.
It has been reported that EV71 3Cpro is required not only
for self-polyprotein processing during the virus replication but
also participates in the disruption of the host immune system
and metabolism by degrading host proteins during infection
(Weng et al., 2009; Lei et al., 2010, 2011, 2013, 2014). To gain
further understanding into the enzymatic properties of 3Cpro
and 3Cpro N69D, we designed six fluorescent-labeled peptides,
three based on the auto-processing sites of EV71 polyprotein and
three corresponding to the reported host targets of EV71 3Cpro
(Table S2). The substrates from EV71 are designated as ES-1,
ES-2, and ES-3, and are based on the 10 residues between 2B–
2C, 2C–3A, and 3B–3C junctions, respectively. HS-1, HS-2, and
HS-3 are feasible substrates of 3C from the host targets CstF-
64, IRF-7, and TRIF, respectively. All of those peptides include
a Gln followed by a small residue (Gly or Ser) serving as the
cleavage site of EV71 3Cpro and are joined with a N-terminal
Dabcyl group and a C-terminal Edans group. When the peptide
bond is cut off by the 3C protease, the fluorescence quenching
pair Dabcyl-Edans is abrogated and fluorescence increase can
be detected by fluorospectrophotometer. Using this method, we
performed in vitro enzyme assays with native 3Cpro, 3Cpro N69D,
and 3Cpro C147S (a negative control was verified to be inactive)
proteins purified from E. coli. Although we triedmany conditions
(data not shown), we still failed to detect the enzyme activity of
3Cpro to HS-2 and HS-3 because of the instability of HS-2 and
HS-3 peptides. However, the reaction kinetics were successfully
analyzed for 3Cpro and 3Cpro N69D against ES-1, ES-2, ES-3 and
HS-1 (Figures 3A–D). 3Cpro and 3Cpro N69D present enzyme
activity against peptides in different levels, and fluorescence
increase was not observed in the system containing 3Cpro C147S.
Three independent measurements were performed. The Km
values of 3Cpro and 3Cpro N69D against the three substrates (ES-
2, ES-3, and HS-1) did not show significant difference, suggesting
the substitution of Asn69 does not affect the affinity between
3Cpro N69D and those substrates despite the change of the charge
in the active site. Remarkably, the Km values of 3Cpro N69D
against ES-1 containing a QS cleavage site showed an obvious
increase indicating the N69D replacement may decrease the
affinity between 3Cpro N69D and certain substrates (Figure 3E).
More importantly, the Kcat values of 3Cpro N69D were reduced
5–10 times for all four substrates (Figure 3F). Most notably,
the cleavage efficiency of 3Cpro N69D against 2B–2C junction
decreased nearly ten times (Table S3). Our results show that
3Cpro N69D has a similar substrate binding affinity as wild-type
3Cpro, but significantly lower enzymatic activity compared with
native 3Cpro.
To better understand the in vivo function, native 3Cpro, 3Cpro
N69D, and 3Cpro C147S were expressed in mammalian cells
using a pFLAG-CMV2 vector which expressed target protein
followed by green fluorescent protein. Previous studies have
shown that wild type 3Cpro of EV71 reduces the expression of
IRF7 by mediating IRF7 cleavage in infected cells (Lei et al.,
2013). Therefore, we next detected the intracellular expression
of IRF7 by immunoblotting. Interestingly, IRF7 was hydrolyzed
in WT 3Cpro-expressed cells but not in either 3Cpro N69D
or 3Cpro C147S-expressing cells (Figure 3G). Previous studies
showed that both EV71 2C and 3C protein targets components of
the NF-κB pathway to inhibit the host’s ability to defend against
virus infection (Lei et al., 2014; Huang et al., 2015; Wang et al.,
2015). We further examined real-time concentrations of NF-κB
in native 3Cpro, 3Cpro N69D, and 3Cpro C147S expressed cells
by immunoblotting. The results showed that the concentration
of NF-κB in 3Cpro C147S-expressed cells was elevated with the
increased expression of 3Cpro C147S protein. In native 3Cpro,
the NF-κB level was decreased significantly at first and then
slowly recovered to the initial concentration. Differently, the
concentration of NF-κB in 3Cpro N69D-expressed cells was
between the levels in native 3Cpro and 3Cpro C147S-expressed
cells, suggesting that EV71 3Cpro could reduce the expression
of NF-κB in a process closely related to its protease activity
(Figure 3G). Together, these experimental results demonstrated
that 3Cpro N69D has decreased enzyme activity and imperfect
antagonism toward the host immune system compared to the
WT 3Cpro.
N69D Replacement of 3Cpro Also Occurs in
Other Natural Viruses
Our data suggests that 3Cpro N69D acts as a subdued protease
both in vivo and in vitro. To determine the frequency of this
variation, we compared the EV71 sequence with five kinds of
picornaviruses, CAV16, PV, CVB, EV68, and HRV, with 94, 72,
57, 54, and 50% identity, respectively (Figure 4). Structure-based
sequence alignment showed that the catalytic triad is highly
conserved in all selected viruses and some important residues
(Arg39, Glu61, and Asp69) that participate in the hydrogen
bonding network to stabilize the catalytic triad are less conserved.
Most remarkably, the 3Cpro Asp69 also exists in other virus
strains in addition to EV71. One strain of CAV16 isolated from
Beijing in 2013 (GenBank code: KF193629) contains Asp rather
than Asn in the 69th residue of 3Cpro sequence, suggesting that
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FIGURE 3 | Catalytic activities of native 3C and 3C N69D tested in vitro and in vivo. (A) The enzyme kinetics of native 3C and 3C N69D for the ES-1 peptide.
The description of the fluorescence-labeled peptides is listed in Table S2. The concentration of the protease was 0.5 µM for all experiments. The initial velocities of
the protease under a variety of different substrate concentrations were plotted against substrate concentrations to obtain the Vmax and Km values of the enzyme. The
kinetic data were fitted with the Michaelis-Menten equation. (B–D) show the enzyme kinetics of WT 3C and 3C N69D to the ES-2 peptide, ES-3 peptide, and HS-1
peptide, respectively. Three independent measurements were performed. (E,F) Comparison of Km and Kcat for the different substrates. Km and Kcat (Vmax/[E]) were
determined respectively. Error bars depict the standard deviation (S.D., n = 3). (G) Effect of WT 3C and 3C N69D on IRF7 and NF-κB in 293T cell. 293T cells were
transfected with GFP or GFP-3C variants as indicated. The intracellular IRF7 and NF-κB was detected using immunoblotting by corresponding antibody at different
times after transfection. GAPDH was included as an internal control.
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FIGURE 4 | Structure-based multiple sequences alignment of 3C homologs from EV71 and other picornaviruses. The secondary structure and residue
numbers are shown on the top. Conserved residues involved in catalytic activity are marked with triangles, The catalytic triad is highlighted with a hot pink background
and others in light pink. Remarkably, the N69D mutation is present in some strains of EV71 and CAV16 and most stains of HRV_C.
mutation in this site is not limited to the single case of EV71,
but may be a secondary type of virus spreading between patients.
More interestingly, we found that the Asp69 is present in HRV
and surprisingly Asp69 was conserved in nearly all C-type HRV
(HRV_C) closely related to asthma in children. No structure
of HRV_C is available in PDB but we can speculate from our
structure that the identity of the 69th reside may lead to great
changes in substrate selection and catalytic activity of HRV_C.
In most strains of A-type HRV, the 69th reside is positively
charged Lys, in contrast to the negatively charged Asp studied
here. Structural analysis reveals that Lys69 attracts Glu71 and
Asp61 forming a stable conformation of the active site.
Model for 3C N69D-Mediated Attenuation
of EV71 Virulence
The above data suggest that the N69D substitution may explain
the attenuation of virulence of the non-lethal strain. First,
the N69D substitution of 3Cpro will result in a subdued viral
reproductivity due to a slower speed to process viral precursor
polypeptides. Previous studies have demonstrated that the
replication ability of the lethal strains were significantly higher
than the non-lethal strain (Li et al., 2016). Second, our result
showed that the hydrolytic activity of 3C N69D to host target
CstF-64, the polyadenylation protein involved in the 3′ end
cleavage and polyadenylation of pre-mRNAs, was 15% of native
3C. As a result, the function of 3Cpro involved in the shutoff
of host cell metabolism might also be affected by the N69D
substitution. Then the inhibition of host cellular transcription
by 3Cpro could be decreased. More importantly, the inhibition of
host immune system mediated by protease activity of 3C will be
crippled as well (Figure 5). To test our hypothesis, we measured
the intracellular production of IFN-α/ IFN-β after infection of
one lethal strain (H) and one non-lethal strain (L) using ELISA
kit. Consistent with our expectations, the concentration of IFN-α
in the non-lethal strain-infected cells was much higher than that
of lethal strain-infected cells in 6, 12, and 24 hpi then tend to be
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FIGURE 5 | Model for 3C N69D-mediated attenuation of EV71 virulence.
The N69D substitution of 3Cpro decreases viral reproductivity due to a slower
processing rate of viral precursor polypeptides. The N69D mutation can also
affect the ability of 3Cpro to promote the shutoff of host cell metabolism by
hydrolysis of CstF-64 and other factors. Most importantly, this substitution
weakens the inhibition of host immune system mediated by protease activity of
3C by hydrolysis of IRF-7 and inhibition of NF-κB pathway. Taken together, the
3C N69D mutation was responsible for the attenuation of EV71 virulence.
similar in 36 hpi (Figure S4). However, IFN-β was not detected
in either the lethal strain or the non-lethal strain-infected cells.
DISCUSSION
In China, hundreds of children are killed by severe hand, foot
and mouth disease every year and the culprit of this severe
HFMD is the EV71 virus (McMinn, 2002; Yang et al., 2009).
However, unlike the poliovirus, no effective drug or vaccine
against EV71 is available, which makes it a serious threat to
the health of children and infants in China and the rest of
the world (Lum et al., 1998; Huang et al., 1999). This virus
belongs to the picornaviridae family and consists of a positive
single-stranded RNA that exhibits frequent variation (Lum et al.,
1998; Ho, 2000). Previous research on the relationship between
viral genetic sequences and virulence mainly focused on two
proteins: VP1 and 3D (Parks et al., 1989; Meng and Kwang,
2014; Zhang et al., 2014; Bhakat, 2015; Yuan et al., 2015). Some
reports showed that a single mutation of VP1 or 3D would
lead to great changes in the severity of symptoms. However,
little is known about the molecular mechanisms underlying these
phenotypes. Furthermore, both the patient’s immune system and
viral genetic sequences contribute to the severity of symptoms so
that in other words, the same virus will cause different symptoms
in different persons (Huang et al., 1999; Weng et al., 2010).
Therefore, mice with the same genetic background are developed
as appropriate models to research the relationship between viral
genetic sequences and patient symptoms.
Our group developed neonatal mice models of the EV71
infection and focused on the mechanisms of mild and severe
symptoms of HFMD, which were caused by slight differences
in genomic sequence. Six EV71 strains that were isolated
from patients of Jinan, in 2008 and 2010, exhibited different
pathogenicity toward neonatal mice (Li et al., 2016). Only eight
differences were found in the amino acid between lethal-strains
and non-lethal strains. To find out the mutation(s) responsible
for the attenuated virulence, eight single point recombinant
virus variants were constructed based on a lethal-strain. The one
that included a substitution in the 69th residue of 3C protease
exhibited different phenotypes compared with the wild type
EV71 and the other reassortant viruses. To better understand
this phenomenon, the structure and function of 3C N69D were
explored in detail. To do this, we first crystallized and solved the
structure of 3C N69D-rupintrivir complex. We found that the
N69D mutation disrupted one of the substrate binding switches
and presented an altered active site conformation. Second,
we discovered that, consistent with the apparent structural
disruption, the catalytic activity of 3CN69D to substrates became
only 1/5–1/10 of the normal 3C protein, which suggests the
69th of the 3C protease was a significant regulatory site of 3C
activity. Further, the in vivo data showed that the inhibitory
ability of 3C N69D to the host targets, IRF7 or NF-κB, was not
as effective as the wild-type 3C protein. All above data suggests
the replication speed of the virus, which contains the 3C N69D
mutation, will be slower. Further to this, the data proposes the
inhibitory function of EV71 to the host’s immune system, which
occurs by decomposing central immune molecules, will also be
crippled thus significantly weakening the pathogenicity of EV71.
One of the deficiencies, however, in this study was that we did
not obtain the culturable virus of M7, despite multiple attempts
throughout the course of our research. The reasons are as follows.
First, by using a normal concentration of RNAs, the activity of 3C
N69D may be too low to produce enough viral proteins to form
new virus particles within a short time. Second, if we use a high
concentration of RNAs, a large number of viral proteins will be
produced and the typical cytopathic effect would appear too fast,
which would restrict the formation of new virus particles.
3C protease is one of the most important proteins involved
in the virus-host interaction and serves as a potent target for
designing anti-EV71 agents (Parks et al., 1989; Reich et al., 2000;
Li et al., 2002; Kuyumcu-Martinez et al., 2004b; Kundu et al.,
2005; Kuo et al., 2008). Our findings broaden our understanding
to the catalytic mechanism of 3C protease and provide new
insights into the structure and function of a subdued 3C protease
mutant, which exists in a wide variety of viruses. It is one of the
most popular research topics: to identify novel cellular proteins
as host substrates of 3C proteases. Our research showed that the
non-lethal virus we isolated from a mild patient, which includes
the 3C N69D mutant, exhibited obvious differences in its ability
to hydrolyze substrates. So more host substrates of 3C protease
will be identified according to the differences in concentration
of proteins of lethal virus and non-lethal virus-infected cells.
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Moreover, the N69D replacement of 3Cpro is identified in a
variety of natural viruses, so detection of this variation might
contribute to the prediction of clinical presentation. In addition
to this, the attenuated non-lethal EV71 variants, with robust
replication profiles, would contribute to the development of both
live attenuated and inactivated EV71 vaccines. However, despite
what our research has accomplished, further data will be needed
to show the significance and universality of N69D replacement of
3C protease as demonstrated in the present study.
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Figure S1 | The typical cytopathic effect of eight recombinant EV71
viruses. The typical cytopathic effect (CPE) of modified EV71 variants transfected
with same amount of RNAs was shown in this picture. (A) Uninfected control; (B)
Cells infected by M1 RNA for 24 h (A12 and other 6 mutations except M7 showed
same phenotype, data not shown); (C) Cells infected by M7 RNA for 48 h.
Figure S2 | Immunoblotting and Indirect fluorescent-antibody results of
WT EV71 and recombinant EV71 viruses. (A) Immunoblotting results of cells
transfected with RNAs of WT or recombinants detected by 3C and 3D antibody.
GADPH was detected as a control. Samples were prepared at 24 h after infection.
H one of lethal strains (GenBank accession no. HQ825317); A12: recombinant
EV71 virus of a lethal strain (GenBank accession no. HQ611148); M1–M8
recombinant EV71 virus with single residue replacement (Table S1). (B) Indirect
fluorescent-antibody results detected by mouse polyclonal antibody to EV71.
Percentages of IFA-positive cells were obviously reduced in M7 but other mutants
were more similar to WT.
Figure S3 | N69D mutant leads to different orientation in P1′ group of
rupintrivir. WT 3C-rupintrivir and 3C N69D -rupintrivir are shown in yellow and
green, respectively. Rupintrivir, Gln 22, His 40, Glu71, and Asp69/Asn69 are
shown in the stick model. the ester chain of P1′ group is exposed to the solvent in
the native 3C structure, while it forms hydrogen bonds with the carbonyl oxygen of
Gln22 in 3C N69D structure.
Figure S4 | The intracellular production of IFN-α in lethal strain and
non-lethal strain infected cell. The concentrations of IFN-α in culture
supernatants of H strain (one of lethal strains, GenBank accession no. HQ825317)
or L strain (the non-lethal strain, GenBank accession no. JF913464) infected cells
were analyzed by ELISA kits.
Table S1 | Sequence alignment results of lethal strains and non-lethal
strain.
Table S2 | Information of peptides used in protease activity assay.
Table S3 | Cleavage efficiencies of EV71 3C WT and N69D mutant.
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